MedTrace Logo

Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences

NCT04955717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-02-03

Study results available
· View outcomes & findings →

Summary

To assess the effectiveness of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing and treatment during pregnancy to reduce adverse pregnancy and birth outcomes compared to the standard of care (treatment based on symptoms and signs).

Conditions

  • Chlamydia Trachomatis Infection
  • Neonatal Infection
  • Preterm Birth
  • Gonorrhea

Interventions

OTHER

Chlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert

Chlamydia trachomatis and Neisseria gonorrhoeae testing using the GeneXpert

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-24
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • United States
  • Botswana

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955717 on ClinicalTrials.gov